What if we could find breast cancers earlier? See lesions more clearly? Reduce the number of unnecessary biopsies?
Questions like these inspired Hologic researchers and scientists to develop Hologic's 3D MAMMOGRAPHY™ technology. With the introduction of Selenia Dimensions, we launched the first commercially available system that delivers on the extraordinary promise of breast tomosynthesis.
Over half of the U.S. News and World Report top 20 cancer hospitals offer Hologic's 3D MAMMOGRAPHY™ technology. More than five million women to date in the United States have already been screened with this life-changing technology, which is now available in 50 states and in over 50 countries.